HHC ACO Inc., an Accountable Care Organization | NYC Health + Hospitals

HHC ACO Inc., an Accountable Care Organization

ACO Name and Location

HHC ACO Inc
199 Water Street, 31st Floor
New York, New York 10038

ACO Primary Contact

Primary Contact Name Lana Vardanian, MD
Primary Contact Phone Number 212-788-3393
Primary Contact Email Address

Organizational Information

ACO participants:

ACO Participants ACO Participant in Joint Venture (Enter Y or N)
New York City Health and Hospitals Corporation Y
Brightpoint Health Y
Community Healthcare Network, Inc. Y
Coney Island Medical Practice Plan, P.C. Y
Downtown Bronx Medical Associates, P.C. Y
Harlem Medical Associates, P.C. Y
Metropolitan Medical Practice Plan, P.C. Y
Mount Sinai Elmhurst Faculty Practice Group Y
University Physicians of Brooklyn Y

ACO governing body:

Member
Last Name First Name Title/Position
Member’s Voting Power Membership Type ACO Participant TIN Legal Business Name/DBA, if Applicable
Katz Mitchell Chair
1 ACO Participant Representative New York City Health and Hospitals Corporation
Chokshi Dave CEO
1 ACO Participant Representative New York City Health and Hospitals Corporation
Anantharam Plachikkat Treasurer
1 ACO Participant Representative New York City Health and Hospitals Corporation
Rocha, Jr. Israel Secretary
1 ACO Participant Representative New York City Health and Hospitals Corporation
Seigel Warren Voting Member
1 ACO Participant Representative Downtown Bronx Medical Associates, P.C.
Berger-Gaskin Jeromane Voting Member
1 Medicare Beneficiary Representative  
Foley William T Voting Member
1 ACO Participant Representative New York City Health and Hospitals Corporation
Diamond Jessica Voting Member
1 ACO Participant Representative Brightpoint Health
Kalkut Gary Voting Member
1 ACO Participant Representative New York City Health and Hospitals Corporation
Marcos Luis Voting Member
1 Other  
Moshirpur Jasmin Voting Member
1 ACO Participant Representative Mt. Sinai Elmhurst Faculty Practice Group

Key ACO clinical and administrative leadership:

Dave Chokshi, MD ACO Executive
Lana Vardanian, MD Medical Director
Catherine Patsos, Esq. Compliance Officer
Lana Vardanian, MD

Associated committees and committee leadership:

Committee Name Committee Leader Name and Position
Governance Committee Mitchell Katz, MD, Board Chair
Clinical Leadership & Quality Assurance Committee Lana Vardanian, MD, Medical Director
Audit Committee Vacant

Types of ACO participants, or combinations of participants, that formed the ACO:

  • ACO professionals in a group practice arrangement
  • Hospital employing ACO professionals
  • Federally Qualified Health Center (FQHC)
  • Electing Teaching Amendment (ETA) hospital

Shared Savings and Losses

Amount of Shared Savings/Losses

  • Second Agreement Period
  • Performance Year 2017, $2,182,360
  • Performance Year 2016, $1,586,859
  • First Agreement Period
  • Performance Year 2015, $6,052,364
  • Performance Year 2014, $2,644,605
  • Performance Year 2013, $3,639,766

Shared Savings Distribution

  • Second Agreement Period
  • Performance Year 2017
  • Proportion invested in infrastructure: 0%
  • Proportion invested in redesigned care processes/resources: 57%
  • Proportion of distribution to ACO participants: 43%
  • Performance Year 2016
  • Proportion invested in infrastructure: 0%
  • Proportion invested in redesigned care processes/resources: 85%
  • Proportion of distribution to ACO participants: 15%
  • First Agreement Period
  • Performance Year 2015
  • Proportion invested in infrastructure: 0%
  • Proportion invested in redesigned care processes/resources: 20%
  • Proportion of distribution to ACO participants: 80%
  • Performance Year 2014
  • Proportion invested in infrastructure: 0%
  • Proportion invested in redesigned care processes/resources: 28%
  • Proportion of distribution to ACO participants: 72%
  • Performance Year 2013
  • Proportion invested in infrastructure: 0%
  • Proportion invested in redesigned care processes/resources: 36%
  • Proportion of distribution to ACO participants: 64%

Quality Performance Results

2017 Quality Performance Results:

ACO# Measure Name Rate ACO Mean
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information 67.05 80.60
ACO-2 CAHPS: How Well Your Providers Communicate 89.24 93.13
ACO-3 CAHPS: Patients’ Rating of Provider 88.19 92.31
ACO-4 CAHPS: Access to Specialists 80.70 83.32
ACO-5 CAHPS: Health Promotion and Education 68.83 62.30
ACO-6 CAHPS: Shared Decision Making 69.87 75.85
ACO-7 CAHPS: Health Status/Functional Status 68.92 73.05
ACO-34 CAHPS: Stewardship of Patient Resources 23.47 25.68
ACO-8 Risk Standardized, All Condition Readmission 15.73 15.01
ACO-35 Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM) 18.42 18.46
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes 59.19 53.95
ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure 102.82 79.16
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 77.21 61.74
ACO-43 Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91)) 1.76 1.93
ACO-11 Use of Certified EHR Technology 100.00 98.48
ACO-12 Medication Reconciliation 86.16 75.32
ACO-13 Falls: Screening for Future Fall Risk 77.20 74.38
ACO-44 Imaging Studies for Low Back Pain 72.13 67.32
ACO-14 Preventive Care and Screening: Influenza Immunization 76.52 72.52
ACO-15 Pneumonia Vaccination Status for Older Adults 87.20 72.92
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up 73.17 70.69
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 94.30 90.48
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 91.45 61.98
ACO-19 Colorectal Cancer Screening 76.19 64.58
ACO-20 Breast Cancer Screening 84.34 70.05
ACO-42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 89.51 79.89
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control 16.13 16.74
ACO-41 Diabetes: Eye Exam 62.50 50.37
ACO-28 Hypertension (HTN): Controlling High Blood Pressure 69.64 71.47
ACO-30 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic 93.38 86.86

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.

Note: In the Quality Performance Results file(s) above, search for “HHC ACO Inc” to view the quality performance results. This ACO can also be found by using the ACO ID A00934 in the public use files on data.cms.gov.

Payment Rule Waivers

  • No, our ACO does not use the SNF 3-Day Rule Waiver.

WE ALWAYS PUT PATIENTS FIRST